The use of decision-making aids has helped atrial fibrillation patients to be more informed about their care, according to a study published in the British Medical Journal (BMJ).

Q4 2024 Earnings Call Transcript February 12, 2025 AtriCure, Inc. beats earnings expectations. Reported EPS is $-0.08, ...

Binge drinking and possibly, moderate alcohol intake, may trigger atrial fibrillation. Caffeine intake does not appear to be a trigger; although, some doctors still recommend that patients with atrial ...

Ethereum Bitcoin, Bitcoin, Ethereum, Litecoin. Read Investing.com (Günay Caymaz)'s Market Analysis on Investing.com CA.

The U.K. is continuing to shape up regulation, adding reform of its accelerated drug approval process and its draft guidance on personalized mRNA cancer vaccines to new clinical trial regulations that ...

History of prior heart failure (HF) was found to influence prognostic implications of atrial fibrillation (AFib) in patients hospitalized for HF, with permutations of prior HF, prior AFib and AFib as ...

Atrial fibrillation is a cardiac arrhythmia in which the upper chambers of the heart the atria beat irregularly and, often, rapidly. The condition occurs as a consequence of uncoordinated ...

Catheter ablation is one of the most effective rhythm-control strategies for atrial fibrillation (AF). Conventional catheter ablation is performed using thermo-energy sources via either radiofrequency ...

For the fourth quarter and full-year 2024, Tempus AI announced its preliminary revenue numbers on Jan. 13. Per the announcement, fourth-quarter preliminary revenues were around $200 million, up 35 ...

The drug received accelerated approval in October 2017 as monotherapy for adults with MCL who have received at least one prior treatment. The FDA simultaneously converted the conditional approval to ...

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study.

It remains to be seen whether abelacimab is clinically effective for stroke prevention in people with atrial fibrillation. For people with atrial fibrillation (Afib), investigational abelacimab ...